SCHEMBL7712652

SCHEMBL7712652

CC(=O)Oc1c2cccc(Cl)c2cc2cccc(Cl)c12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.46
KDM4E B2RXH2 4/20 0.46
ALDH1A1 P00352 4/20 0.46
GAA P10253 3/20 0.46
KMT2A Q03164 3/20 0.46
TDP1 Q9NUW8 3/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
POLB P06746 2/20 0.46
APEX1 P27695 1/20 0.46
RECQL P46063 1/20 0.46
BLM P54132 1/20 0.46
HTT P42858 3/20 0.43
HSD17B10 Q99714 2/20 0.43
TP53 P04637 1/20 0.43
ABCB11 O95342 1/20 0.42
MEN1 O00255 2/20 0.40
CYP3A4 P08684 2/20 0.40
MCL1 Q07820 1/20 0.40
HIF1A Q16665 1/20 0.40
ALOX12 P18054 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7710152 0.82 MAPT (0.43) MAPTKDM4EALDH1A1GAAKMT2A
SCHEMBL29368592 0.81 KDM4E (0.47) MAPTKDM4EALDH1A1GAAKMT2A
SCHEMBL7712641 0.80 KMT2A (0.47) MAPTKDM4EALDH1A1GAAKMT2A
SCHEMBL8837593 0.78 GAA (0.57) MAPTKDM4EALDH1A1GAAKMT2A
SCHEMBL9430129 0.74 HTT (0.57) MAPTKDM4EALDH1A1GAAKMT2A
SCHEMBL3006462 0.73 KDM4E (0.48) MAPTKDM4EALDH1A1GAAKMT2A
SCHEMBL9642267 0.73 ABCB11 (0.55) MAPTKDM4EALDH1A1GAAKMT2A
SCHEMBL7714721 0.72 CYP1A2 (0.37) MAPTTDP1L3MBTL1HTTCYP1A2
SCHEMBL8781224 0.72 MAPT (0.43) MAPTKDM4EALDH1A1GAAKMT2A
SCHEMBL27615297 0.72 KDM4E (0.51) MAPTKDM4EALDH1A1GAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6369246-B2 ANTIALLERGENS, ANTIINFLAMMATORY AGENTS, ANTITUMOR AGENTS DR. KEITH CHAN, GLOBOASIA, LLC 2002-04-09 US disclosed
US-20010018539-A1 Synthesis and pharmaceuticals of novel 9-substituted-1, 5-dichloroanthracene analogs CHAN, KEITH 2001-08-30 US disclosed
WO-2000061536-A2 SYNTHESIS AND PHARMACEUTICALS OF NOVEL 9-SUBSTITUTED-1,5-DICHLOROANTHRACENE ANALOGS GLOBOASIA, L.L.C. (US) 2000-10-19 WO disclosed
US-3941836-A SOLUBILIZERS, PLASTICIZER, UV ABSORBER THE LUBRIZOL CORPORATION (US) 1976-03-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010018539-A1 Synthesis and pharmaceuticals of novel 9-substituted-1, 5-dichloroanthracene analogs C3AR1, C5AR2, TLR2 MAPT 4591/4885KDM4E 1082/4885ALDH1A1 143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.